Connect to other sites within the UBM Medica Network
Panitumumab Failed in KRAS Wild-Type Biliary Tract Cancer
Adding the EGFR-targeting drug panitumumab to chemotherapy had no effect on survival in a group of patients with wild-type KRAS status advanced biliary tract cancer.
Blood Clots in Abdomen May Be Sign of Cancer
The presence of an abdominal blood clot may be a sign of cancer and may also be associated with poor survival for patients with pancreatic or liver cancers.
PD-1 Inhibitor Yields Responses in Hepatocellular Carcinoma
In this video, Dr. El-Khoueiry discusses results from a phase I/II study that suggest the PD-1 inhibitor nivolumab is safe and effective in advanced hepatocellular carcinoma.
Early Trial Finds Immunotherapy Effective in Liver Cancer
Results from a phase I/II study suggest that the immunotherapy nivolumab is safe and effective in advanced hepatocellular carcinoma (HCC).
Aflatoxin Linked to Risk of Gallbladder Cancer
Aflatoxin, a naturally occurring toxin produced by certain types of molds, has been found to be associated with an increased risk of gallbladder cancer.
Statins Linked With Reduced Liver Cancer in Low-Rate Areas
Current use of statins was associated with about a 50% decreased risk for liver cancer, according to results of a study looking at data from the United Kingdom.
RT Effective for Palliation of Bone Metastases From HCC
A recent study found that radiation therapy was effective for the palliation of painful spinal metastases in patients with hepatocellular carcinoma.
By clicking Accept, you agree to become a member of the UBM Medica Community.